IFNB1 and myeloid sarcoma: In addition, we could show that multiple treatments including dimethyl fumarate, interferon beta and fingolimod all lead to a significantly decreased peripheral blood memory B cell fraction (36) pointing at a pathophysiologic role of memory B cells in MS.